Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_676b80da7ac92b84e447a83fb1630ae1 |
classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2500-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2333-70557 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2333-65 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2317-34 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-1777 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P13-12 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P19-08 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P19-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P27-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-78 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K16-2848 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-5011 |
classificationIPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-00 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-50 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K16-28 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K16-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K14-78 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-17 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-16 |
filingDate |
2005-05-06-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
grantDate |
2010-05-25-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8fab7ed94cb0a402486d245bc9ced96a http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_80d6589951430a4350e8c429cee861d1 |
publicationDate |
2010-05-25-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
US-7723483-B2 |
titleOfInvention |
Method for enhancing or inhibiting insulin-like growth factor-I |
abstract |
The present invention provides αVβ3 integrin cysteine loop domain agonists and antagonists (including peptide agonists and antagonists and analogs thereof), along with methods of using the same. |
isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8187595-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8206706-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9045541-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9345739-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9073996-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9068000-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9868787-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9663575-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9587024-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2009280127-A1 |
priorityDate |
2004-05-07-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |